Showing results (1191-1200 of 1,196) with videos related to
Sort By:
Pageof 120
You have reached the last page of results.This site can display upto 1,196 results.
NAR Cancer|July 28, 2021
Characterization of a <i>RAD51C</i>-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistanceRachel M Hurley, Cordelia D McGehee, Ksenija Nesic, et al.Journal of Medicinal Chemistry|October 6, 2021
Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic DisordersHuji Turdi, Hannguang Chao, Jon J Hangeland, et al.Lancet (London, England)|November 15, 2024
Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trialJianwen Guo, Xiaoying Chen, Manli Wu, et al.Molecular Cell|August 26, 2021
Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesisChun Gong, Joanna A Krupka, Jie Gao, et al.Cell Reports. Medicine|June 21, 2023
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomasMarkus Bredel, Lluís Espinosa, Hyunsoo Kim, et al.Journal of Medicinal Chemistry|February 18, 2022
Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1<i>H</i>-pyrazol-1-yl)methyl)phosphonate (BMS-820132)Yan Shi, Ying Wang, Wei Meng, et al.Pageof 120